Fourth Quarter 2013 Results
Algeta’s 4Q and 2013 FY financial results are available
Algeta has successfully combined cutting-edge research with commercial know-how.
Combining expertise in radiochemistry, nuclear medicine, and medical oncology, Algeta is at the forefront of alpha-pharmaceutical research.
The Algeta share is listed on the Oslo Stock Exchange under the ticker code ALGETA. All shares are freely transferable.